IL138625A0 - Novel nucleic acid transfer agents, compositions containing same and uses - Google Patents

Novel nucleic acid transfer agents, compositions containing same and uses

Info

Publication number
IL138625A0
IL138625A0 IL13862599A IL13862599A IL138625A0 IL 138625 A0 IL138625 A0 IL 138625A0 IL 13862599 A IL13862599 A IL 13862599A IL 13862599 A IL13862599 A IL 13862599A IL 138625 A0 IL138625 A0 IL 138625A0
Authority
IL
Israel
Prior art keywords
nucleic acid
compositions containing
transfer agents
containing same
novel nucleic
Prior art date
Application number
IL13862599A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9804121A external-priority patent/FR2777017B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL138625A0 publication Critical patent/IL138625A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL13862599A 1998-04-02 1999-03-30 Novel nucleic acid transfer agents, compositions containing same and uses IL138625A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9804121A FR2777017B1 (fr) 1998-04-02 1998-04-02 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications
US8584598P 1998-05-18 1998-05-18
PCT/FR1999/000740 WO1999051581A1 (fr) 1998-04-02 1999-03-30 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications

Publications (1)

Publication Number Publication Date
IL138625A0 true IL138625A0 (en) 2001-10-31

Family

ID=26234240

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13862599A IL138625A0 (en) 1998-04-02 1999-03-30 Novel nucleic acid transfer agents, compositions containing same and uses

Country Status (12)

Country Link
EP (1) EP1068188A1 (ko)
JP (1) JP2002513543A (ko)
KR (1) KR20010042318A (ko)
CN (1) CN1294582A (ko)
AU (1) AU759301B2 (ko)
BR (1) BR9909350A (ko)
CA (1) CA2324931A1 (ko)
HU (1) HUP0102455A3 (ko)
IL (1) IL138625A0 (ko)
NO (1) NO317225B1 (ko)
PL (1) PL342886A1 (ko)
WO (1) WO1999051581A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
ITMI20050222A1 (it) 2005-02-15 2006-08-16 Milano Politecnico Lipidi cationici per la trasfezione di acidi nucleici

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645866B1 (fr) * 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
FR2714830B1 (fr) * 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2727679B1 (fr) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2741066B1 (fr) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
CZ295225B6 (cs) * 1996-03-01 2005-06-15 Centre National De La Recherche Scientifique Amidiniový derivát a farmaceutický prostředek tento derivát obsahující

Also Published As

Publication number Publication date
NO20004780D0 (no) 2000-09-25
EP1068188A1 (fr) 2001-01-17
AU3406100A (en) 2000-11-30
NO317225B1 (no) 2004-09-20
JP2002513543A (ja) 2002-05-14
KR20010042318A (ko) 2001-05-25
AU759301B2 (en) 2003-04-10
CN1294582A (zh) 2001-05-09
WO1999051581A1 (fr) 1999-10-14
HUP0102455A3 (en) 2003-09-29
NO20004780L (no) 2000-11-01
PL342886A1 (en) 2001-07-16
CA2324931A1 (fr) 1999-10-14
HUP0102455A2 (hu) 2001-10-28
BR9909350A (pt) 2000-12-12

Similar Documents

Publication Publication Date Title
PL342081A1 (en) Novel quaternary ammonia compounds, compositions containing them and their application
PL341372A1 (en) Cellecoxibe containing compositions
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
HUP0203505A3 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, and pharmaceutical compositions containing said compounds
PL338186A1 (en) Beneficial agent compositions containing alpha-hydroxyesters
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
AU4289399A (en) Nucleic acid transfer phage
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
HUP0004375A3 (en) Composition containing azelaic acid
PL339920A1 (en) Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide
IL138624A0 (en) Nucleic acid transfer vectors, compositions containing same and uses
EP1208268A4 (en) NOVEL QUATERNARY COMPOUNDS, COMPOSITIONS CONTAINING THESE COMPOUNDS AND CORRESPONDING USES THEREOF
HUP0200345A3 (en) Novel nucleic acid transferring agents, compositions containing them and uses
GB9704643D0 (en) Chemical composition
PL342165A1 (en) Antienzymic composition containing ethylenediamino disuscinic acid
HUP0102455A3 (en) Novel nucleic acid transfer agents, compositions containing same and uses
GB9923882D0 (en) Chemical composition
GB9715908D0 (en) Chemical composition
ZA992262B (en) Vectors for transferring nucleic acids, compositions containing them and their uses.
EP1135476A4 (en) BIOLOGICAL COMPOSITIONS, COMPONENTS THEREOF AND APPLICATIONS THEREOF
GB9819600D0 (en) Chemical compositions
IL142278A0 (en) Imidazo-isoquinoline compounds, their compositions and uses
GB9822490D0 (en) Nucleic acid
GB9823481D0 (en) Nucleic acid